- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
OREX Market Currents
more »
-
May 10 Other drug stocks are reacting to the FDA decision on Arena Pharmaceuticals (ARNA) Locaserin: OREX +10%, VVUS +2.3%
2 Comments[Healthcare, On the Move]
OREX in Focus
more »
OREX Related Articles
more »
OREX News
more »
-
at MarketWatch.com (May 12, 2012)
-
at MarketWatch.com (May 11, 2012)
-
at CNBC.com (May 11, 2012)
-
at CNBC.com (May 11, 2012)
-
at CNBC.com (May 11, 2012)
OREX Press Releases and Filings
more »
-
PR Newswire (May 14, 2012)
-
PR Newswire (May 9, 2012)
-
PR Newswire (May 8, 2012)
-
PR Newswire (May 1, 2012)
-
PR Newswire (Apr 27, 2012)
OREX Latest Transcript
more »
OREX Cramer
more »
-
Mon, Oct 5, 2009
-
Fri, Aug 14, 2009
OREX Instablog posts
more »
OREX vs. ETF Alternatives
Company Description
We were incorporated in Delaware in September 2002. Our principal offices are located at 3344 N. Torrey Pines Court, Suite 200, La Jolla, California 92037, and our telephone number is (858) 875-8600. Our website address is www.orexigen.com. Information found on, or accessible through, our... More
